Indeed, the targeted deletion of DOR in Nav1.8-expressing nociceptors prevents from the endogenous opioid-mediated analgesia at the latter phase of the DSS-induced colitis when T lymphocytes accumulate within the inflamed mucosa. Here, OPRD1 is linked to colitis.